-
Emerging Antimicrobial Strategies Against Heterogeneous and Vancomycin-Intermediate Staphylococcus aureus
11 Sep 2025 06:04 GMT
… by high rates of vancomycin treatment failure, compounded by limited … therapeutic responses necessitates precision medicine approaches. Clinical isolates … of Nisin V. Microb Biotechnol. 2010;3(4):473 … doi:10.3390/pharmaceutics15061636
98. Nasaj M, Farmany …
-
Drug-Drug Interactions and Initial Dosage Optimization of Quetiapine in Patients with Depression: A Real-World Study
09 Sep 2025 10:53 GMT
… with antidepressant medications is the primary treatment method.9 … delirium: randomized controlled trial. Neurocrit Care. 2024 … regimen optimization of vancomycin in Southern Chinese … to predict metabolic drug-drug interaction. Drug Metab Pharmacokinet. …
-
Acute Kidney Injury Associated with the Concomitant Use of Vancomycin and Piperacillin-Tazobactam
09 Sep 2025 05:59 GMT
… lack randomized controlled trials, AUC-guided … Pharmaceutical Association—Hengrui Research Foundation of Hospital Pharmacy (H202305) and Nanjing Medical … injury during treatment with vancomycin in combination … in Therapeutic Drug Monitoring of Vancomycin? A …
-
4 Analysts Have This To Say About ANI Pharmaceuticals
08 Sep 2025 20:45 GMT
… Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two … .
Return on Assets (ROA): ANI Pharmaceuticals';s financial strength is … financial health.
Debt Management: ANI Pharmaceuticals';s debt-to-equity …
-
World Sepsis Day 2025: more investment needed to tackle healthcare burden
12 Sep 2025 17:19 GMT
… and targeted treatment options.
At present, sepsis treatment predominantly … tazobactam, vancomycin and meropenem. But these types of drugs have … medicine approach. In the AdrenOSS-2 Phase II trial, … to benefit from enibarcimab treatment. Enibarcimab was found …
-
Introducing the September/October 2025 Infection Control Today Print Edition
10 Sep 2025 17:59 GMT
This issue of Infection Control Today® (ICT®) dives deep into some of the most urgent challenges and promising innovations shaping infection prevention today. Our cover story double feature tackles Candida auris, the multidrug-resistant fungal threat that …
-
Regulatory tracker: FDA cancels adcomm for Travere's kidney disease drug Filspari
02 Jul 2025 21:48 GMT
… clinical trials.
The Chinese National Medical Products … a doctor';s office … drug, excluding in the U.S., through a November 2024 deal with ARS Pharmaceuticals … FDA’s blessing for a new, ready-to-infuse formulation of the antibiotic vancomycin for the treatment …
-
Compatibility and Physico-Chemical Stability of Six Intravenous Mixtures for Postoperative Multimodal Analgesia
09 Sep 2025 10:52 GMT
… active pharmaceutical ingredients and support the need for drug–device … and Faculty of Pain Medicine (2020), Acute Pain … guidelines for prevention and treatment (article in Spanish). Rev … al. Stability of 5% vancomycin ophthalmic solution prepared using …
-
Efficacy of Multidisciplinary Team-Based Cardiopulmonary Rehabilitation in Improving Outcomes for Patients with Intensive Care Unit-Acquired Weakness: A Retrospective Cohort Study
11 Sep 2025 19:59 GMT
… limb strengthening). Existing trials often suffer from … delivering cardiopulmonary rehabilitation treatments; and a rehabilitation … symptoms, disease status, medical and nursing services, … Staphylococcus aureus: beyond Vancomycin. Critical Care Nurs. …
-
Researchers develop modified glue gun that can print bone — device 3D prints synthetic grafts directly onto patients’ living tissue during surgery
11 Sep 2025 15:40 GMT
… they could include antibiotics like vancomycin and gentamycin into the mixture … and easier for both the medical team and the patient.
Follow …